Asher Biotherapeutics, Inc. is a biotechnology company dedicated to developing precisely targeted immunotherapies for cancer and other diseases. Through its innovative cis-targeting platform, Asher Bio aims to selectively activate specific immune cell types, addressing limitations found in traditional immunotherapies. The company's advanced approach has the potential to optimize immune response, facilitating the development of a pipeline of best-in-class therapies for various conditions, including cancer, autoimmune diseases, and infectious diseases. With a mission rooted in restoring hope and health to patients, Asher Bio emphasizes teamwork, inspiration, and rigorous strategic decision-making as foundational to its operations. The company values diversity and inclusivity, fostering a collaborative environment where employees can excel and contribute to transformative healthcare solutions.